Psoriatic Arthritis

High fatigue common in psoriatic arthritis

High fatigue common in psoriatic arthritis

Nearly 50% of patients with psoriatic arthritis report elevated levels of fatigue.

FDA approves Inflectra biosimilar for rheumatoid arthritis, psoriasis

FDA approves Inflectra biosimilar for rheumatoid arthritis, psoriasis

By

The biosimilar has also been approved for Crohn's disease, ulcerative colitis, and ankylosing spondylitis.

Severe psoriasis, nail pitting possible risks for development of psoriatic arthritis

Severe psoriasis, nail pitting possible risks for development of psoriatic arthritis

Researchers found that the annual incidence rate of PsA was 2.7 cases per 100 psoriasis patients.

PALACE 1 study confirms safety, efficacy of apremilast for psoriatic arthritis

PALACE 1 study confirms safety, efficacy of apremilast for psoriatic arthritis

Apremilast was generally well tolerated among participants in the long-term PALACE 1 study.

Combination use of methotrexate and golimumab may significantly improve psoriatic arthritis symptoms

Combination use of methotrexate and golimumab may significantly improve psoriatic arthritis symptoms

Using methotrexate and golimumab in combination may significantly improve some symptoms among patients diagnoes with psoriatic arthritis.

Sign Up for Free e-newsletters